Indication
Cryopyrin-Associated Periodic Syndrome
Cryopyrin-Associated Periodic Syndrome (CAPS) refers to a spectrum of rare, inherited autoinflammatory disorders caused by gain-of-function mutations in the *NLRP3* gene, which encodes the protein cryopyrin. Read more about Cryopyrin-Associated Periodic Syndrome
0 drugs 0 manufacturers
Drugs that treat it
Common Cryopyrin-Associated Periodic Syndrome therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCryopyrin-Associated Periodic Syndrome (CAPS) refers to a spectrum of rare, inherited autoinflammatory disorders caused by gain-of-function mutations in the *NLRP3* gene, which encodes the protein cryopyrin.
These mutations cause hyperactivation of the NLRP3 inflammasome, precipitating unrestrained, excessive secretion of the proinflammatory cytokine interleukin-1 beta (IL-1ß).
The condition predominantly presents in infancy or early childhood and encompasses a continuum of clinical severity, ranging from familial cold autoinflammatory syndrome to Muckle-Wells syndrome and neonatal-onset multisystem inflammatory disease.
Patients experience recurrent or persistent systemic inflammation characterized by periodic fevers, urticaria-like skin rashes, and arthralgias, with more severe manifestations including sensorineural hearing loss, chronic aseptic meningitis, ocular inflammation, skeletal deformities, and secondary amyloidosis.
- nih.gov
Cryopyrin-Associated Periodic Syndrome (CAPS) refers to a spectrum of rare, inherited autoinflammatory disorders caused by gain-of-function mutations in the *NLRP3* gene, which encodes the protein cryopyrin These mutations cause hyperactivation of the NLRP3 inflammasome, precipitating unrestrained, excessive secretion of the proinflammatory cytokine interleukin-1 beta (IL-1β) The condition predominantly presents in infancy or early childhood and encompasses a continuum of clinical severity, rang...
- yalemedicine.org
Cryopyrin-Associated Periodic Syndrome (CAPS) refers to a spectrum of rare, inherited autoinflammatory disorders caused by gain-of-function mutations in the *NLRP3* gene, which encodes the protein cryopyrin
- nih.gov
These mutations cause hyperactivation of the NLRP3 inflammasome, precipitating unrestrained, excessive secretion of the proinflammatory cytokine interleukin-1 beta (IL-1β) Patients experience recurrent or persistent systemic inflammation characterized by periodic fevers, urticaria-like skin rashes, and arthralgias, with more severe manifestations including sensorineural hearing loss, chronic aseptic meningitis, ocular inflammation, skeletal deformities, and secondary amyloidosis
- aiarthritis.org
The condition predominantly presents in infancy or early childhood and encompasses a continuum of clinical severity, ranging from familial cold autoinflammatory syndrome to Muckle-Wells syndrome and neonatal-onset multisystem inflammatory disease
- medlineplus.gov
Patients experience recurrent or persistent systemic inflammation characterized by periodic fevers, urticaria-like skin rashes, and arthralgias, with more severe manifestations including sensorineural hearing loss, chronic aseptic meningitis, ocular inflammation, skeletal deformities, and secondary amyloidosis
Personalize your experience
Follow Cryopyrin-Associated Periodic Syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.